On Background  ·   December 19, 2013

Why the FDA cracked down on 23andMe

- Dr. Robert Klitzman, of Columbia University's Masters in Bioethics Program, discusses the stiff backlash that direct-to-consumer genetic testing firm 23andMe recently faced from the FDA. ()

- Dr. Robert Klitzman, of Columbia University's Masters in Bioethics Program, discusses the stiff backlash that direct-to-consumer genetic testing firm 23andMe recently faced from the FDA. ()

Why the FDA cracked down on 23andMe (1:44)

buildnumber:5d30c1